Vertex Pharmaceuticals
VRTX
#142
Rank
C$177.23 B
Marketcap
$688.20
Share price
-1.49%
Change (1 day)
22.60%
Change (1 year)

P/S ratio for Vertex Pharmaceuticals (VRTX)

P/S ratio as of February 2025 (TTM): 11.7

According to Vertex Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.93. At the end of 2024 the company had a P/S ratio of 11.2.

P/S ratio history for Vertex Pharmaceuticals from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202411.25.83%
202310.627.99%
20228.3012.49%
20217.38-25.49%
20209.90-27.3%
201913.6-1.82%
201813.9-8.89%
201715.241.87%
201610.7-64.24%
201530.0-39.33%
201449.5245.26%
201314.3140.39%
20125.9621.42%
20114.91-90.13%
201049.7-40.87%
200984.1243.25%
200824.557.95%
200715.5-28.9%
200621.817.27%
200518.6123.8%
20048.31-31.45%
200312.161.36%
20027.51-46.1%
200113.9

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.32-62.97%๐Ÿ‡บ๐Ÿ‡ธ USA
6.14-47.34%๐Ÿ‡บ๐Ÿ‡ธ USA
3.53-69.77%๐Ÿ‡บ๐Ÿ‡ธ USA
2.46-78.95%๐Ÿ‡บ๐Ÿ‡ธ USA
4.21-63.86%๐Ÿ‡บ๐Ÿ‡ธ USA
1.56-86.58%๐Ÿ‡บ๐Ÿ‡ธ USA